{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:00:02Z","timestamp":1780668002533,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2844"],"award-info":[{"award-number":["FOR2844"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2844"],"award-info":[{"award-number":["FOR2844"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FOR2844"],"award-info":[{"award-number":["FOR2844"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["FNR\/DFG 11250962"],"award-info":[{"award-number":["FNR\/DFG 11250962"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The mechanism(s) causing selective vulnerability of dopaminergic neurons in Parkinson\u2019s disease (PD) remain largely elusive. To improve our understanding of mitochondrial involvement and related pathways suggested to play a role in this selective vulnerability, we used tyrosine hydroxylase (TH)-mCherry reporter-induced pluripotent stem cells generated by CRISPR\/Cas9. We sorted neurons into pure TH-positive and TH-negative neurons upon differentiation into a dopaminergic neuron-containing cell culture. We characterized mitochondrial function in both dopaminergic and non-dopaminergic neurons from PD patients and controls and identified differentially expressed genes between patients and controls in both cell populations. Dopaminergic neurons had a lower mitochondrial membrane potential than non-dopaminergic neurons. Furthermore, ATP levels were lower in\n                    <jats:italic>PRKN<\/jats:italic>\n                    mutation carriers than controls, and mitochondrial mass was reduced in\n                    <jats:italic>PRKN<\/jats:italic>\n                    mutation carriers only in the TH-positive but not in TH-negative neurons. Importantly, in\n                    <jats:italic>PRKN<\/jats:italic>\n                    mutation carriers, we demonstrated elevated levels of dopamine, which can serve as a significant source of toxic, oxidized dopamine. Using unbiased RNA sequencing, we detected increased levels of\n                    <jats:italic>CHCHD2<\/jats:italic>\n                    and decreased expression of\n                    <jats:italic>GPNMB<\/jats:italic>\n                    in TH-positive neurons from Parkin mutation carriers compared to healthy controls. This suggests a possible interaction of these three PD genes in response to a dopaminergic neuron-specific increase in oxidative stress, which further leads to the selective vulnerability of dopaminergic neurons.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-08926-4","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:44:49Z","timestamp":1780663489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective vulnerability of dopaminergic neurons in Parkinson\u2019s disease connects PRKN and differential expression of CHCHD2 and GPNMB"],"prefix":"10.1038","volume":"17","author":[{"given":"Franca","family":"Vulinovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7557-2391","authenticated-orcid":false,"given":"Arian","family":"Hach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zied","family":"Landoulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Tanzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Alvarez-Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Seibler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8698-3770","authenticated-orcid":false,"given":"Patrick","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8127-7911","authenticated-orcid":false,"given":"Aleksandar","family":"Rakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"8926_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"8926_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Inoue H, Wu JC, Yamanaka S. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017;16:115\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"8926_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, Shim J-W, Piao J, Ganat YM, Wakeman DR, Xie Z, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature. 2011;480:547\u201351.","journal-title":"Nature"},{"key":"8926_CR4","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.celrep.2017.02.023","volume":"18","author":"N Xia","year":"2017","unstructured":"Xia N, Fang F, Zhang P, Cui J, Tep-Cullison C, Hamerley T, et al. A knockin reporter allows purification and characterization of mDA neurons from heterogeneous populations. Cell Rep. 2017;18:2533\u201346.","journal-title":"Cell Rep"},{"key":"8926_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.817198","volume":"16","author":"A Rakovic","year":"2022","unstructured":"Rakovic A, Vo\u00df D, Vulinovic F, Meier B, Hellberg A-K, Nau C, et al. Electrophysiological properties of induced pluripotent stem cell-derived midbrain dopaminergic neurons correlate with expression of tyrosine hydroxylase. Front Cell Neurosci. 2022;16:817198.","journal-title":"Front Cell Neurosci"},{"key":"8926_CR6","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1093\/brain\/awae188","volume":"147","author":"A Westenberger","year":"2024","unstructured":"Westenberger A, Skrahina V, Usnich T, Beetz C, Vollstedt E-J, Laabs B-H, et al. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson\u2019s disease study. Brain. 2024;147:2652\u201367.","journal-title":"Brain"},{"key":"8926_CR7","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/mds.27352","volume":"33","author":"M Kasten","year":"2018","unstructured":"Kasten M, Hartmann C, Hampf J, Schaake S, Westenberger A, Vollstedt E-J, et al. Genotype-phenotype relations for the Parkinson\u2019s disease genes Parkin, PINK1, DJ1: MDSGene systematic review. Mov Disord. 2018;33:730\u201341.","journal-title":"Mov Disord"},{"key":"8926_CR8","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1474-4422(14)70266-2","volume":"14","author":"M Funayama","year":"2015","unstructured":"Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, et al. CHCHD2 mutations in autosomal dominant late-onset Parkinson\u2019s disease: a genome-wide linkage and sequencing study. Lancet Neurol. 2015;14:274\u201382.","journal-title":"Lancet Neurol"},{"key":"8926_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abk0637","volume":"377","author":"ME Diaz-Ortiz","year":"2022","unstructured":"Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, et al. GPNMB confers risk for Parkinson\u2019s disease through interaction with \u03b1-synuclein. Science. 2022;377:eabk0637.","journal-title":"Science"},{"key":"8926_CR10","unstructured":"DRAGEN RNA Pipeline. https:\/\/www.illumina.com\/products\/by-type\/informatics-products\/basespace-sequence-hub\/apps\/edico-genome-inc-dragen-rna-pipeline.html (accessed 24 Sept2025)."},{"key":"8926_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"8926_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene Ontology: tool for the unification of biology. Nat Genet. 2000;25:25\u201329.","journal-title":"Nat Genet"},{"key":"8926_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M. Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"8926_CR14","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.","journal-title":"Innovation"},{"key":"8926_CR15","doi-asserted-by":"crossref","unstructured":"Krajka V, Vulinovic F, Genova M, Tanzer K, Jijumon AS, Bodakuntla S et al. H-ABC\u2013 and dystonia-causing TUBB4A mutations show distinct pathogenic effects. Sci Adv. 2022;8:eabj9229.","DOI":"10.1126\/sciadv.abj9229"},{"key":"8926_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer C, Wang T, Michaelos M, Pachitariu M. Cellpose: a generalist algorithm for cellular segmentation. Nat Methods. 2021;18:100\u20136.","journal-title":"Nat Methods"},{"key":"8926_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.660843","volume":"13","author":"TR Kee","year":"2021","unstructured":"Kee TR, Espinoza Gonzalez P, Wehinger JL, Bukhari MZ, Ermekbaeva A, Sista A, et al. Mitochondrial CHCHD2: disease-associated mutations, physiological functions, and current animal models. Front Aging Neurosci. 2021;13:660843.","journal-title":"Front Aging Neurosci"},{"key":"8926_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-genome wide association study. Lancet Neurol. 2019;18:1091\u2013102.","journal-title":"Lancet Neurol"},{"key":"8926_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bcmd.2016.12.002","volume":"68","author":"V Murugesan","year":"2018","unstructured":"Murugesan V, Liu J, Yang R, Lin H, Lischuk A, Pastores G, et al. Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Blood Cells Mol Dis. 2018;68:47\u201353.","journal-title":"Blood Cells Mol Dis"},{"key":"8926_CR20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/gerona\/glac245","volume":"78","author":"S Zhou","year":"2023","unstructured":"Zhou S, Tian Y, Song X, Xiong J, Cheng G. Brain proteome-wide and transcriptome-wide asso-ciation studies, bayesian colocalization, and Mendelian randomization analyses reveal causal genes of Parkinson\u2019s disease. J Gerontol A Biol Sci Med Sci. 2023;78:563\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"8926_CR21","first-page":"1500","volume":"31","author":"MK Nguyen","year":"2022","unstructured":"Nguyen MK, McAvoy K, Liao S-C, Doric Z, Lo I, Li H, et al. Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2. Hum Mol Genet. 2022;31:1500\u201318.","journal-title":"Hum Mol Genet"},{"key":"8926_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101656","volume":"41","author":"C \u00dcberbacher","year":"2019","unstructured":"\u00dcberbacher C, Obergasteiger J, Volta M, Venezia S, M\u00fcller S, Pesce I, et al. Application of CRISPR\/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons. Stem Cell Res. 2019;41:101656.","journal-title":"Stem Cell Res"},{"key":"8926_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-021-00771-0","volume":"14","author":"M Yokota","year":"2021","unstructured":"Yokota M, Kakuta S, Shiga T, Ishikawa K, Okano H, Hattori N, et al. Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons. Mol Brain. 2021;14:58.","journal-title":"Mol Brain"},{"key":"8926_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107044","volume":"26","author":"DA Beccano-Kelly","year":"2023","unstructured":"Beccano-Kelly DA, Cherubini M, Mousba Y, Cramb KML, Giussani S, Caiazza MC, et al. Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson\u2019s iPSC-dopamine neurons. iScience. 2023;26:107044.","journal-title":"iScience"},{"key":"8926_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science. 2017;357:1255\u201361.","journal-title":"Science"},{"key":"8926_CR26","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/nature04788","volume":"441","author":"J Park","year":"2006","unstructured":"Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature. 2006;441:1157\u201361.","journal-title":"Nature"},{"key":"8926_CR27","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1074\/jbc.M112.391680","volume":"288","author":"A Rakovic","year":"2013","unstructured":"Rakovic A, Shurkewitsch K, Seibler P, Gr\u00fcnewald A, Zanon A, Hagenah J, et al. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous parkin attenuates mitophagy. J Biol Chem. 2013;288:2223\u201337.","journal-title":"J Biol Chem"},{"key":"8926_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen D-F, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183:795\u2013803.","journal-title":"J Cell Biol"},{"key":"8926_CR29","doi-asserted-by":"publisher","first-page":"e32866","DOI":"10.7554\/eLife.32866","volume":"7","author":"G-L McLelland","year":"2018","unstructured":"McLelland G-L, Goiran T, Yi W, Dorval G, Chen CX, Lauinger ND, et al. Mfn2 ubiquitination by PINK1\/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy. eLife. 2018;7:e32866.","journal-title":"eLife"},{"key":"8926_CR30","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.bbadis.2018.05.018","volume":"1864","author":"Y Xi","year":"2018","unstructured":"Xi Y, Feng D, Tao K, Wang R, Shi Y, Qin H, et al. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1\u03b1. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis. 2018;1864:2859\u201370.","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis Dis"},{"key":"8926_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.bbadis.2017.02.016","volume":"1863","author":"F Zhao","year":"2017","unstructured":"Zhao F, Wang W, Wang C, Siedlak SL, Fujioka H, Tang B, et al. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson\u2019s disease. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis. 2017;1863:1359\u201370.","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis Dis"},{"key":"8926_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1154-0","volume":"9","author":"S Franco-Iborra","year":"2018","unstructured":"Franco-Iborra S, Cuadros T, Parent A, Romero-Gimenez J, Vila M, Perier C. Defective mitochondrial protein import contributes to complex I-induced mitochondrial dysfunction and neurodegeneration in Parkinson\u2019s disease. Cell Death Dis. 2018;9:1122.","journal-title":"Cell Death Dis"},{"key":"8926_CR33","doi-asserted-by":"publisher","first-page":"e12962","DOI":"10.1371\/journal.pone.0012962","volume":"5","author":"A Gr\u00fcnewald","year":"2010","unstructured":"Gr\u00fcnewald A, Voges L, Rakovic A, Kasten M, Vandebona H, Hemmelmann C, et al. Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts. PLoS One. 2010;5:e12962.","journal-title":"PLoS One"},{"key":"8926_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson\u2019s disease. J Parkinson's Dis. 2013;3:461\u201391.","journal-title":"J Parkinson's Dis"},{"key":"8926_CR35","first-page":"3881","volume":"27","author":"X Huang","year":"2018","unstructured":"Huang X, Wu BP, Nguyen D, Liu Y-T, Marani M, Hench J, et al. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum Mol Genet. 2018;27:3881\u20133900.","journal-title":"Hum Mol Genet"},{"key":"8926_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15500","volume":"8","author":"H Meng","year":"2017","unstructured":"Meng H, Yamashita C, Shiba-Fukushima K, Inoshita T, Funayama M, Sato S, et al. Loss of Parkinson\u2019s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat Commun. 2017;8:15500.","journal-title":"Nat Commun"},{"key":"8926_CR37","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/s41418-019-0482-7","volume":"27","author":"W Liu","year":"2020","unstructured":"Liu W, Duan X, Xu L, Shang W, Zhao J, Wang L, et al. Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1. Cell Death Differ. 2020;27:2014\u201329.","journal-title":"Cell Death Differ"},{"key":"8926_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2184-y","volume":"10","author":"J-E Bae","year":"2019","unstructured":"Bae J-E, Kang GM, Min SH, Jo DS, Jung Y-K, Kim K, et al. Primary cilia mediate mitochondrial stress responses to promote dopamine neuron survival in a Parkinson\u2019s disease model. Cell Death Dis. 2019;10:952.","journal-title":"Cell Death Dis"},{"key":"8926_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03441-0","volume":"12","author":"M Bi","year":"2021","unstructured":"Bi M, Du X, Jiao Q, Chen X, Jiang H. Expanding the role of proteasome homeostasis in Parkinson\u2019s disease: beyond protein breakdown. Cell Death Dis. 2021;12:154.","journal-title":"Cell Death Dis"},{"key":"8926_CR40","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","volume":"330","author":"DT Dexter","year":"1987","unstructured":"Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, et al. Increased nigral iron content in postmortem Parkinsonian brain. Lancet. 1987;330:1219\u201320.","journal-title":"Lancet"},{"key":"8926_CR41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.molmed.2022.02.003","volume":"28","author":"Z-L Wang","year":"2022","unstructured":"Wang Z-L, Yuan L, Li W, Li J-Y. Ferroptosis in Parkinson\u2019s disease: glia\u2013neuron crosstalk. Trends Mol Med. 2022;28:258\u201369.","journal-title":"Trends Mol Med"},{"key":"8926_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21669-4","volume":"12","author":"E Sinclair","year":"2021","unstructured":"Sinclair E, Trivedi DK, Sarkar D, Walton-Doyle C, Milne J, Kunath T, et al. Metabolomics of sebum reveals lipid dysregulation in Parkinson\u2019s disease. Nat Commun. 2021;12:1592.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08926-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:59:33Z","timestamp":1780664373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08926-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8926"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08926-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CK has served as a medical advisor to Centogene, Biogene, and Bial and has received speakers\u2019 honoraria from Bial and royalties from Oxford University Press and Springer Nature. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experimental procedures were conducted in accordance with relevant institutional guidelines and regulations. All procedures involving human participants were conducted in accordance with institutional ethical standards and the Declaration of Helsinki. The study protocol was reviewed and approved by the Ethics Committee of the University of L\u00fcbeck (04-155 and 05-030). Written informed consent was obtained from all participants prior to tissue collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"544"}}